ARCHIVES

Conversation With The Cancer Letter: Hudis: ASCO Vying for Big Role in Big Data

This article is from The Cancer Letter archive.

Vol. 39 No. 44 | November 22, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

July 28, 1995

NCI Supports Development Of Reinoids for Prevention; No Magic Bullet

May 6, 1977

Cancer.gov Knocked Offline By Theft Of Routers

July 11, 2003

Scientists, Advocates Voice Objections To von Eschenbach’s Conflicts, 2015.

November 22, 2006

Mammography: Panel Member Quits Over “One-Sided” Document

February 14, 1997

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004